Edition:
United States

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

171.20EUR
17 Feb 2017
Change (% chg)

-- (--)
Prev Close
€171.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,600
52-wk High
€197.95
52-wk Low
€127.00

VIRB.PA

Chart for VIRB.PA

About

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €1,448.01
Shares Outstanding(Mil.): 8.46
Dividend: --
Yield (%): --

Financials

  VIRB.PA Industry Sector
P/E (TTM): 54.81 28.47 29.39
EPS (TTM): 3.12 -- --
ROI: 2.62 13.57 13.06
ROE: 6.03 14.45 14.19

BRIEF-Virbac Q4 net revenue up to 225.7 million euros

* Q4 net revenue 225.7 million euros ($241.41 million) versus 206.2 million euros year ago

Jan 17 2017

BRIEF-Virbac Q3 revenue rises to 216.3 million euros

* Reported on Thursday 9-month revenue 646.2 million euros ($723.81 million) versus 646.0 million euros year ago

Oct 14 2016

UPDATE 1-Virbac cuts revenue forecast on U.S., Chile market conditions

Sept 19 French veterinary pharmaceutical firm Virbac reported a jump in first-half earnings on Monday but trimmed its 2016 revenue growth forecasts due to difficulties in the United States and Chile, as well as a negative currency impact.

Sep 19 2016

BRIEF-Virbac H1 revenue down 0.5 pct at 430.0 million euros

* H1 revenue 430.0 million euros ($480.61 million) versus 432.3 million euros year ago

Sep 19 2016

More From Around the Web

Earnings vs. Estimates